🇺🇸 biphasic human insulin in United States

biphasic human insulin (biphasic human insulin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

biphasic human insulin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is biphasic human insulin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for biphasic human insulin in United States?

Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.